Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Opendoor Stock Is a Speculative Name

By Josh Enomoto, InvestorPlace Contributor

Thanks to its iBuying innovations, Opendoor stock has benefitted from delivering next-generation solutions. But will that be enough?

9 Stocks Selling at a Discount Right Now

By Josh Enomoto, InvestorPlace Contributor

One of the surprising developments of 2020 was the tremendous rise of the equities market. However, there are still undervalued opportunities to be had with these stocks selling at a discount.

Pfizer Faces a New Perception Risk You Shouldn’t Ignore

By Josh Enomoto, InvestorPlace Contributor

Pfizer stock was earlier a key benefactor from the coronavirus vaccine race, but a new perceptional risk is weighing on shares.

Don’t Let SPAC Hype Detract You From Churchill Capital Corp IV

By Josh Enomoto, InvestorPlace Contributor

Forget the rumor mill surrounding CCIV stock; the real story is how Lucid Motors is making all the right business decisions.

Hyliion Holdings Isn’t a Comforting Play But That’s Not the Whole Story

By Josh Enomoto, InvestorPlace Contributor

On multiple levels, including the weak economy and rising competitive threats, HYLN stock doesn’t make sense. However, if you don’t mind volatility, Hyliion offers short-term upside potential.

Load More